Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| EZCLONE Cloning Manufacturings | | 5.4 | | | | | | |
| Growlife | | 1.6 | | | | | | |
| Total revenues | 6.2 | 7.0 | 8.2 | 4.6 | 2.5 | 1.2 | 3.5 | 0.0 |
| Revenue growth | -11.5% | -14.8% | 79.7% | 86.5% | 99.2% | -64.8% | | -100.0% |
| Cost of goods sold | 3.4 | 4.0 | 5.7 | 4.1 | 2.2 | 1.3 | 3.0 | 0.0 |
| Gross profit | 2.8 | 3.0 | 2.5 | 0.5 | 0.3 | 0.0 | 0.5 | 0.0 |
| Gross margin | 45.1% | 42.6% | 31.0% | 10.2% | 11.1% | -3.6% | 14.8% | |
| Selling, general and administrative [+] | | | 7.0 | 5.0 | 2.3 | 1.9 | 2.7 | |
| General and administrative | 0.0 | 0.0 | 7.0 | 5.0 | 2.3 | 1.9 | 2.7 | 0.0 |
| Other selling, general and administrative | | | | | | | | |
| Other operating expenses | 4.3 | 4.9 | | 0.1 | | 0.9 | 2.1 | |
| EBITDA [+] | -1.5 | -1.9 | -4.4 | -4.5 | -2.0 | -2.8 | -4.2 | |
| EBITDA growth | -19.7% | -57.6% | -3.5% | 121.3% | -26.9% | -33.8% | | -100.0% |
| EBITDA margin | -24.0% | -26.5% | -53.2% | -99.1% | -83.5% | -227.4% | -120.9% | |
| Depreciation | -0.6 | -0.6 | -0.7 | -0.1 | 0.0 | 0.0 | 0.0 | |
| EBITA | -0.9 | -1.2 | -3.6 | -4.5 | -2.0 | -2.8 | -4.2 | 0.0 |
| EBITA margin | -13.8% | -17.4% | -44.1% | -97.7% | -83.6% | -228.1% | -121.3% | |
| Amortization of intangibles | 0.7 | 0.7 | 0.8 | 0.1 | | | | |
| EBIT [+] | -1.5 | -1.9 | -4.5 | -4.6 | -2.0 | -2.8 | -4.2 | 0.0 |
| EBIT growth | -19.3% | -57.6% | -3.2% | 125.0% | -27.1% | -33.8% | | -100.0% |
| EBIT margin | -24.6% | -27.0% | -54.3% | -100.8% | -83.6% | -228.1% | -121.3% | |
| Non-recurring items [+] | | | 0.6 | -0.1 | | | -2.1 | |
| Asset impairment | | | | -0.1 | | | | |
| Unusual expense | | | | | | | -2.1 | |
| Loss on contingent liability | | | | | | | -2.1 | |
| Interest expense | 0.4 | 0.2 | 1.2 | 1.3 | 1.3 | 0.8 | 1.1 | |
| Interest expense | 0.4 | 0.2 | 1.2 | 1.3 | 1.3 | 0.8 | 1.1 | |
| Other income (expense), net [+] | 1.9 | 1.9 | -1.3 | -5.6 | -2.0 | -4.1 | -2.4 | |
| Asset impairment charges | | | | | | 0.9 | | |
| Gain (loss) on debt retirement | 1.0 | | | | | | | |
| Gain (loss) on derivative instruments | -1.0 | 0.2 | 0.5 | 1.0 | 0.5 | -1.3 | 1.7 | |
| Other | | | | | | | -3.5 | |
| Pre-tax income | 0.0 | -0.2 | -7.5 | -11.5 | -5.3 | -7.7 | -5.7 | 0.0 |
| Income taxes | 0.0 | 0.2 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 1.6% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Minority interest | | | -0.1 | 0.0 | | | | |
| Net income | -5.5 | -6.4 | -7.3 | -11.4 | -5.3 | -7.7 | -5.7 | 0.0 |
| Net margin | -88.3% | -91.1% | -88.7% | -250.2% | -217.0% | -624.9% | -162.6% | |
| |
| Basic EPS [+] | ($0.07) | ($0.17) | ($0.29) | ($0.58) | $0.00 | ($0.01) | ($0.01) | $0.00 |
| Growth | -62.7% | -39.9% | -49.7% | 22044.0% | -59.5% | -0.1% | | -100.0% |
| Diluted EPS [+] | ($0.07) | ($0.17) | ($0.29) | ($0.58) | $0.00 | ($0.01) | ($0.01) | $0.00 |
| Growth | -62.7% | -39.9% | -49.7% | 22044.0% | -59.5% | -0.1% | | -100.0% |
| |
| Shares outstanding (basic) [+] | 83.8 | 35.3 | 25.1 | 19.9 | 2,044.5 | 1,197.6 | 884.3 | 834.5 |
| Growth | 137.4% | 40.3% | 26.6% | -99.0% | 70.7% | 35.4% | 6.0% | 40.7% |
| Shares outstanding (diluted) [+] | 83.8 | 35.3 | 25.1 | 19.9 | 2,044.5 | 1,197.6 | 884.3 | 834.5 |
| Growth | 137.4% | 40.3% | 26.6% | -99.0% | 70.7% | 35.4% | 6.0% | 40.7% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|